Feeds:
Posts
Comments

Archive for the ‘Net Cash Stocks’ Category

Oozing Alpha on Furiex Pharmaceuticals Inc. (NASDAQ:FURX)

Posted in Net Cash Stocks, Stocks, tagged , on August 18, 2010 | 3 Comments »

Farukh Farooqi has a typically excellent post at Oozing Alpha on Furiex Pharmaceuticals Inc. (NASDAQ:FURX): FURX, spun off from PPDI on 6/14/10, is a $10 stock with net cash (cash minus all liabilities) of $10 per share. It earns royalties on two drugs already in the market with potential milestone payments of $14.40 per share. [...]

Read Full Post »

Forward Industries Inc (NASDAQ:FORD) 2009 10K update

Posted in Activist Investors, Forward Industries Inc (NASDAQ:FORD), Net Cash Stocks, Net Net Stocks, Stocks, tagged , , , on December 14, 2009 | 6 Comments »

Forward Industries Inc (NASDAQ:FORD) has filed its 10K for the period ended September 30, 2009. We started following FORD (see the post archive here) because it was trading at a discount to its net cash and liquidation values, although there was no obvious catalyst. Management appeared to be considering a “strategic transaction” of some kind, [...]

Read Full Post »

CoSine Communications Inc (OTC:COSN) Q3 10Q update

Posted in Activist Investors, CoSine Communications Inc (OTC:COSN), Net Cash Stocks, Steel Partners, Stocks, tagged , , , on November 9, 2009 | Leave a Comment »

CoSine Communications Inc (OTC:COSN) has released its 10Q for the quarter ended September 30, 2009. We’ve been following COSN (see Greenbackd’s COSN post archive) because it is a cash box controlled by activist investor Steel Partners. Steel Partners own 47.5% of the stock and sits on the board. The stock is up 11.4% since our [...]

Read Full Post »

FORD fires its bank, hires another one better able to spend your cash

Posted in Forward Industries Inc (NASDAQ:FORD), Net Cash Stocks, Stocks, tagged , , on October 30, 2009 | Leave a Comment »

Forward Industries Inc (NASDAQ:FORD) has fired its investment and engaged another. It looks like FORD is intent on spending the cash on its balance sheet, which is a shame. Rather than make an acquisition, they should focus on the work on their desk and pay a big dividend. There’s a half chance that the bank [...]

Read Full Post »

VXGN board sued by shareholders over OXGN deal

Posted in Activist Investors, Net Cash Stocks, Net Net Stocks, Stocks, VaxGen Inc (OTC:VXGN), tagged , , , on October 22, 2009 | 24 Comments »

Disgruntled VaxGen Inc (OTC:VXGN) shareholders have initiated a class action against the board of VXGN over possible breaches of fiduciary duty in the sale to OXGN. The board certainly deserves the suit because of the appalling deal struck with OXGN. Priced at a discount to VXGN’s net cash and liquidation values, and payment in the [...]

Read Full Post »

VXGN Full Value Committee nominates director candidates; VXGN clarifies rights to AIDS vaccine

Posted in Activist Investors, Net Cash Stocks, Stocks, VaxGen Inc (OTC:VXGN), tagged , , , on September 30, 2009 | 6 Comments »

It’s been a big week for VaxGen Inc (OTC:VXGN). On Tuesday last week the “VaxGen Full Value Committee” nominated five director candidates to the board. Then on Thursday BizJournals.com reported that VXGN’s “failed AIDS vaccine” was “successful in a new trial that combined it with another failed vaccine in reducing the risk of becoming infected [...]

Read Full Post »

Cadus Corporation (OTC:KDUS)

Posted in Activist Investors, Cadus Corporation (OTC:KDUS), Carl Icahn, Net Cash Stocks, Net Net Stocks, Special Situation, Stocks, tagged , , , , , on September 29, 2009 | 7 Comments »

Cadus Corporation (OTC:KDUS) is an interesting play, but not without hairs on it. First, the good news: It’s trading at a discount to net cash with Carl Icahn disclosing an activist holding in 2002, and Moab Capital Partners disclosing an activist holding more recently. At its $1.51 close yesterday, the company has a market capitalization of [...]

Read Full Post »

Capstone Therapeutics (NASDAQ:CAPS) position exited

Posted in Biotechnology Value Fund, Net Cash Stocks, OrthoLogic Corporation (NASDAQ:CAPS), Stocks, tagged , on September 17, 2009 | Leave a Comment »

We’ve decided to exit our position in OrthoLogic Corporation (NASDAQ:CAPS) at its $0.90 close yesterday. We opened the position at $0.60, so we’re up 50% on an absolute basis. The S&P500 Index closed at 752.83 on February 27, the day we opened the position, and closed yesterday at 1,068.76, which means we’re up 8.0% on [...]

Read Full Post »

VXGN investors form “VaxGen Full Value Committee” to conduct proxy fight

Posted in Activist Investors, Net Cash Stocks, Spencer Capital Management, Stocks, VaxGen Inc (OTC:VXGN), tagged , , , on September 10, 2009 | 9 Comments »

A group of investors in VaxGen Inc (OTC:VXGN) have formed the “VaxGen Full Value Committee” to conduct a proxy contest to replace the current board of VXGN at the next annual shareholders meeting. The group, comprising BA Value Investors’ Steven N. Bronson and ROI Capital Management’s Mark T. Boyer and Mitchell J. Soboleski, intends to [...]

Read Full Post »

Guest Post: Aspen Exploration Corporation (OTC:ASPN)

Posted in Aspen Exploration Corporation (OTC:ASPN), Net Cash Stocks, Net Net Stocks, tagged , , on September 3, 2009 | 12 Comments »

We were going to stay away until after Labor Day, but this is too good to miss. From reader MCN1 on Aspen Exploration Corporation (OTC:ASPN): Company Name: Aspen Exploration Corporation Ticker: ASPN Market Cap: $6.53M (as of 9/2/09) Stock Price: $0.90 (as of 9/2/09) Company Overview: Aspen Exploration Corporation is engaged in the exploration and [...]

Read Full Post »

Older Posts »

Follow

Get every new post delivered to your Inbox.

Join 812 other followers